載入...
BET bromodomains as novel epigenetic targets for brain health and disease
Epigenetic pharmacotherapy for CNS-related diseases is a burgeoning area of research. In particular, members of the bromodomain and extra-terminal domain (BET) family of proteins have emerged as intriguing therapeutic targets due to their putative involvement in an array of brain diseases. With thei...
Na minha lista:
| 發表在: | Neuropharmacology |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7655633/ https://ncbi.nlm.nih.gov/pubmed/32946883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2020.108306 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|